Calyxha is developing novel therapies targeting tissue degeneration that is the fundamental underlying cause of major human diseases.
EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one of the two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
The MoonVision GmbH is a young company located in the heart of Vienna, Austria, focussed on transferring expert know-how to AI using visual information. The company was founded in August 2017, and was awarded with the title “Startup of the year” in 2017. In 2018 it was nominated for the “Go Silicon Valley Program” by WKO and won over partners like Audi, A1, Sacher and Miba. MoonVision detects item type and amounts on a visual basis using proprietary computer vision algorithms and triggers events, like the optimization of machines, payment processes or data generation.
crystalsol develops an entirely new type of flexible photovoltaic technology. The patented technology combines the advantages of high efficiency single-crystalline materials and low cost roll-to-roll production. The technology is based on decades of research for the Russian military and Philips semiconductor know-how from the 1960s. The core innovation is the light absorbing layer made of a patented new crystalline semiconductor powder. The light absorbing active layer of the film is made of crystalline semiconductor particles with a typical diameter of 40 μm arranged as a single layer fixed by a polymer film. The semiconductor particles contain the abundant and low-cost elements copper, zinc, tin, sulphur, and selenium (CZTS). Every semiconductor particle is coated with an extremely thin buffer layer to create the p/n junction. Before the crystalline powder enters the module production it is already a finished working solar cell. The module production process is based on roll-to-roll technology ensuring high throughput and yield similar to the printing industry. Consequently the required investment in crystalsol’s manufacturing equipment is significantly below current capital requirements for photovoltaic plants. Main reason is the elimination of vacuum technology for the active layer and the low process temperatures. Due to the characteristics of crystalsol’s technology upscaling issues – common for thin film technologies – are minimized. As every semiconductor particle is a tiny photovoltaic cell it does not make a difference how large the finished film is. This is an advantage compared to all thin film technologies where all upscaling to larger areas requires costly and time consuming development.
AIRBORNE ROBOTICS drones are delivered worldwide as a complete package, including all the relevant software as well as flight training. The moment one of their customers receives his new AIR6 or AIR8, he can immediately get down to business. The carrier system of an AIR6/8 can accommodate a variety of cameras: Film and photo, thermal imaging cameras, infrared, and diverse measuring sensors for environmental analysis. The system can therefore be adapted to the widest array of applications. Designed as an open platform for developers, specialists from many different fields can program an AIR flying robot for their own purposes and flight jobs, since the interfaces and software are freely accessible.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
crystalsol develops an entirely new type of flexible photovoltaic technology. The patented technology combines the advantages of high efficiency single-crystalline materials and low cost roll-to-roll production. The technology is based on decades of research for the Russian military and Philips semiconductor know-how from the 1960s. The core innovation is the light absorbing layer made of a patented new crystalline semiconductor powder. The light absorbing active layer of the film is made of crystalline semiconductor particles with a typical diameter of 40 μm arranged as a single layer fixed by a polymer film. The semiconductor particles contain the abundant and low-cost elements copper, zinc, tin, sulphur, and selenium (CZTS). Every semiconductor particle is coated with an extremely thin buffer layer to create the p/n junction. Before the crystalline powder enters the module production it is already a finished working solar cell. The module production process is based on roll-to-roll technology ensuring high throughput and yield similar to the printing industry. Consequently the required investment in crystalsol’s manufacturing equipment is significantly below current capital requirements for photovoltaic plants. Main reason is the elimination of vacuum technology for the active layer and the low process temperatures. Due to the characteristics of crystalsol’s technology upscaling issues – common for thin film technologies – are minimized. As every semiconductor particle is a tiny photovoltaic cell it does not make a difference how large the finished film is. This is an advantage compared to all thin film technologies where all upscaling to larger areas requires costly and time consuming development.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
CONDA is the Austrian Crowd Investing platform for corporate investments and corporate finance.
Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria. The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications. Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis. Nabriva entered into an exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA to market, sell and distribute SIVEXTRO® (tedizolid phosphate) in the United States and certain of its territories.
CONDA is the Austrian Crowd Investing platform for corporate investments and corporate finance.
crystalsol develops an entirely new type of flexible photovoltaic technology. The patented technology combines the advantages of high efficiency single-crystalline materials and low cost roll-to-roll production. The technology is based on decades of research for the Russian military and Philips semiconductor know-how from the 1960s. The core innovation is the light absorbing layer made of a patented new crystalline semiconductor powder. The light absorbing active layer of the film is made of crystalline semiconductor particles with a typical diameter of 40 μm arranged as a single layer fixed by a polymer film. The semiconductor particles contain the abundant and low-cost elements copper, zinc, tin, sulphur, and selenium (CZTS). Every semiconductor particle is coated with an extremely thin buffer layer to create the p/n junction. Before the crystalline powder enters the module production it is already a finished working solar cell. The module production process is based on roll-to-roll technology ensuring high throughput and yield similar to the printing industry. Consequently the required investment in crystalsol’s manufacturing equipment is significantly below current capital requirements for photovoltaic plants. Main reason is the elimination of vacuum technology for the active layer and the low process temperatures. Due to the characteristics of crystalsol’s technology upscaling issues – common for thin film technologies – are minimized. As every semiconductor particle is a tiny photovoltaic cell it does not make a difference how large the finished film is. This is an advantage compared to all thin film technologies where all upscaling to larger areas requires costly and time consuming development.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
crystalsol develops an entirely new type of flexible photovoltaic technology. The patented technology combines the advantages of high efficiency single-crystalline materials and low cost roll-to-roll production. The technology is based on decades of research for the Russian military and Philips semiconductor know-how from the 1960s. The core innovation is the light absorbing layer made of a patented new crystalline semiconductor powder. The light absorbing active layer of the film is made of crystalline semiconductor particles with a typical diameter of 40 μm arranged as a single layer fixed by a polymer film. The semiconductor particles contain the abundant and low-cost elements copper, zinc, tin, sulphur, and selenium (CZTS). Every semiconductor particle is coated with an extremely thin buffer layer to create the p/n junction. Before the crystalline powder enters the module production it is already a finished working solar cell. The module production process is based on roll-to-roll technology ensuring high throughput and yield similar to the printing industry. Consequently the required investment in crystalsol’s manufacturing equipment is significantly below current capital requirements for photovoltaic plants. Main reason is the elimination of vacuum technology for the active layer and the low process temperatures. Due to the characteristics of crystalsol’s technology upscaling issues – common for thin film technologies – are minimized. As every semiconductor particle is a tiny photovoltaic cell it does not make a difference how large the finished film is. This is an advantage compared to all thin film technologies where all upscaling to larger areas requires costly and time consuming development.
mechatronic systemtechnik gmbh has developed and manufactured equipment for the semiconductor industry since 1998. They specialise in handling wafers > 50 µm. The company is headquartered in Villach, Austria.
Marinomed is a biopharmaceutical development company focusing on the development of innovative therapies based on patent protected technology platforms. Products against respiratory viruses derived from the proprietary MAVIREX platform are marketed with renowned partners in a growing number of countries around the globe. The new MARINOSOLV platform allows novel stable aqueous formulations of hardly soluble compounds such as corticosteroids, enabling a faster onset of action and a better bioavailability. The MARINOSOLV technology is not limited to a specific compound and has the potential to facilitate delivery of any compound with solubility issues. Marinomed was founded on 2006 and is headquartered in Vienna, Austria.
EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
crystalsol develops an entirely new type of flexible photovoltaic technology. The patented technology combines the advantages of high efficiency single-crystalline materials and low cost roll-to-roll production. The technology is based on decades of research for the Russian military and Philips semiconductor know-how from the 1960s. The core innovation is the light absorbing layer made of a patented new crystalline semiconductor powder. The light absorbing active layer of the film is made of crystalline semiconductor particles with a typical diameter of 40 μm arranged as a single layer fixed by a polymer film. The semiconductor particles contain the abundant and low-cost elements copper, zinc, tin, sulphur, and selenium (CZTS). Every semiconductor particle is coated with an extremely thin buffer layer to create the p/n junction. Before the crystalline powder enters the module production it is already a finished working solar cell. The module production process is based on roll-to-roll technology ensuring high throughput and yield similar to the printing industry. Consequently the required investment in crystalsol’s manufacturing equipment is significantly below current capital requirements for photovoltaic plants. Main reason is the elimination of vacuum technology for the active layer and the low process temperatures. Due to the characteristics of crystalsol’s technology upscaling issues – common for thin film technologies – are minimized. As every semiconductor particle is a tiny photovoltaic cell it does not make a difference how large the finished film is. This is an advantage compared to all thin film technologies where all upscaling to larger areas requires costly and time consuming development.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
Marinomed is a biopharmaceutical development company focusing on the development of innovative therapies based on patent protected technology platforms. Products against respiratory viruses derived from the proprietary MAVIREX platform are marketed with renowned partners in a growing number of countries around the globe. The new MARINOSOLV platform allows novel stable aqueous formulations of hardly soluble compounds such as corticosteroids, enabling a faster onset of action and a better bioavailability. The MARINOSOLV technology is not limited to a specific compound and has the potential to facilitate delivery of any compound with solubility issues. Marinomed was founded on 2006 and is headquartered in Vienna, Austria.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
Focusing on end-to-end systems and tools that provide actionable intelligence based on open sources (TV, FM Radio, Internet, Social Media, Feeds, Websites, and YouTube), SAIL LABS Technology offers cutting-edge technologies in areas such as automatic speech recognition, speaker identification, named entity detection as well as topic detection across multiple languages, geographies and sources. Content based search along with visualization components (clustering, relationships, trends, GIS), workflow features, profiles & ontologies as well as a Social Media Extension complete the product portfolio.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
Marinomed is a biopharmaceutical development company focusing on the development of innovative therapies based on patent protected technology platforms. Products against respiratory viruses derived from the proprietary MAVIREX platform are marketed with renowned partners in a growing number of countries around the globe. The new MARINOSOLV platform allows novel stable aqueous formulations of hardly soluble compounds such as corticosteroids, enabling a faster onset of action and a better bioavailability. The MARINOSOLV technology is not limited to a specific compound and has the potential to facilitate delivery of any compound with solubility issues. Marinomed was founded on 2006 and is headquartered in Vienna, Austria.
crystalsol develops an entirely new type of flexible photovoltaic technology. The patented technology combines the advantages of high efficiency single-crystalline materials and low cost roll-to-roll production. The technology is based on decades of research for the Russian military and Philips semiconductor know-how from the 1960s. The core innovation is the light absorbing layer made of a patented new crystalline semiconductor powder. The light absorbing active layer of the film is made of crystalline semiconductor particles with a typical diameter of 40 μm arranged as a single layer fixed by a polymer film. The semiconductor particles contain the abundant and low-cost elements copper, zinc, tin, sulphur, and selenium (CZTS). Every semiconductor particle is coated with an extremely thin buffer layer to create the p/n junction. Before the crystalline powder enters the module production it is already a finished working solar cell. The module production process is based on roll-to-roll technology ensuring high throughput and yield similar to the printing industry. Consequently the required investment in crystalsol’s manufacturing equipment is significantly below current capital requirements for photovoltaic plants. Main reason is the elimination of vacuum technology for the active layer and the low process temperatures. Due to the characteristics of crystalsol’s technology upscaling issues – common for thin film technologies – are minimized. As every semiconductor particle is a tiny photovoltaic cell it does not make a difference how large the finished film is. This is an advantage compared to all thin film technologies where all upscaling to larger areas requires costly and time consuming development.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis. Nabriva entered into an exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA to market, sell and distribute SIVEXTRO® (tedizolid phosphate) in the United States and certain of its territories.
Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis. Nabriva entered into an exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA to market, sell and distribute SIVEXTRO® (tedizolid phosphate) in the United States and certain of its territories.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
mechatronic systemtechnik gmbh has developed and manufactured equipment for the semiconductor industry since 1998. They specialise in handling wafers > 50 µm. The company is headquartered in Villach, Austria.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.
Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.
Identec Solutions provides its customers with RFID based solutions to help better manage their processes and track whatever their particular situation requires. They focus on a number of sectors, including automotive, transportation, logistics, oil, gas, offshore, mining, marine and ports. Founded in 1999, IDENTEC SOLUTIONS immediately set the industry standard in the RFID industry with the introduction of its Intelligent Long Range® (ILR®) technology, a breakthrough in the world of low-power, long-range wireless communication. In 2006, IDENTEC SOLUTIONS acquired a premier industrial RFID supplier to the automotive industry. Today, one of every three vehicles is manufactured with wireless technology pioneered by IDENTEC SOLUTIONS. The acquisition of WTEK in 2007, a Norway based personnel safety solution provider to the Oil, Gas, Tunnel and Mining industries, led to the expansion of IDENTEC SOLUTIONS’ award-winning RFID technology portfolio, which enabled the company to become an established provider of complete solutions to this burgeoning market. The 2010 acquisition of Sattel from DP World fuelled IDENTEC SOLUTIONS’ ongoing commitment to offering complete, high-value applications and technologies for the Marine and Intermodal industry.